ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 269 filers reported holding ARGENX SE in Q4 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $35,861,459 | +157.2% | 72,944 | +103.9% | 0.09% | +84.3% |
| Q2 2023 | $13,942,201 | +187.1% | 35,774 | +174.5% | 0.05% | +142.9% |
| Q1 2023 | $4,855,463 | -65.9% | 13,032 | -65.4% | 0.02% | -72.4% |
| Q4 2022 | $14,251,206 | +201.2% | 37,619 | +180.7% | 0.08% | +171.4% |
| Q3 2022 | $4,732,000 | +23.8% | 13,402 | +5.9% | 0.03% | -41.7% |
| Q3 2021 | $3,822,000 | +50.4% | 12,657 | +50.0% | 0.05% | +65.5% |
| Q2 2021 | $2,541,000 | -27.2% | 8,439 | -33.4% | 0.03% | -47.3% |
| Q1 2021 | $3,488,000 | +81.1% | 12,667 | +93.4% | 0.06% | +103.7% |
| Q4 2020 | $1,926,000 | -46.8% | 6,549 | -59.2% | 0.03% | -49.1% |
| Q2 2020 | $3,619,000 | +276.6% | 16,067 | +168.3% | 0.05% | +76.7% |
| Q4 2019 | $961,000 | – | 5,988 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |